Zydelig

Active Ingredient(s): Idelalisib
FDA Approved: * July 23, 2014
Pharm Company: * GILEAD SCIENCES INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Zydelig Overview

Idelalisib (trade name Zydelig zye-DEL-ig,[2] codenamed GS-1101 or CAL-101) is a drug used for the treatment of certain hematological malignancies. The substance acts as a phosphoinositide 3-kinase inhibitor; more specifically, it blocks P110δ, the delta isoform of the enzyme phosphoinositide 3-kinase.[3][4] It was developed by Gilead Sciences. Contents 1 Medical uses 2 Clinical trials 3 Adverse effects 4 Pharmacology 4.1 Mechanism of ...

Read more Zydelig Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Idelalisib

Recent Zydelig Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Idelalisib
  • Tablet: 100mg, 150mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Zydelig: (2 results)

Sorted by National Drug Code
  • 61958-1701 Zydelig 100 mg Oral Tablet, Film Coated by Gilead Sciences, Inc.
  • 61958-1702 Zydelig 150 mg Oral Tablet, Film Coated by Gilead Sciences, Inc.

Other drugs which contain Idelalisib or a similar ingredient: (1 result)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 12 December 2018.

We are committed to your privacy.

Copyright © 2005-2018 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA